Length-independent telomere damage drives post-mitotic cardiomyocyte senescence
Open accessPublished version of a preprint
The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index; 17 of the 28 sources its claims cite were checked for support.
Abstract
Abstract Ageing is the biggest risk factor for cardiovascular disease. Cellular senescence, a process driven in part by telomere shortening, has been implicated in age‐related tissue dysfunction. Here, we address the question of how senescence is induced in rarely dividing/post‐mitotic cardiomyocytes and investigate whether clearance of senescent cells attenuates age‐related cardiac dysfunction. During ageing, human and murine cardiomyocytes acquire a senescent‐like phenotype characterised by persistent DNA damage at telomere regions that can be driven by mitochondrial dysfunction and crucially can occur independently of cell division and telomere length. Length‐independent telomere damage in cardiomyocytes activates the classical senescence‐inducing pathways, p21 CIP and p16 INK4a , and results in a non‐canonical senescence‐associated secretory phenotype, which is pro‐fibrotic and pro‐hypertrophic. Pharmacological or genetic clearance of senescent cells in mice alleviates detrimental features of cardiac ageing, including myocardial hypertrophy and fibrosis. Our data describe a mechanism by which senescence can occur and contribute to age‐related myocardial dysfunction and in the wider setting to ageing in post‐mitotic tissues.
Overview
CoChat Summary
## TL;DR
The paper argues that ageing cardiomyocytes acquire a senescent-like state through persistent telomere-associated DNA damage that is independent of telomere shortening, cell division, and telomerase activity. Clearing senescent cells in mice reduced cardiomyocyte hypertrophy and fibrosis, suggesting a therapeutic angle for age-related cardiac dysfunction.
## Key findings
- In mouse and human hearts, mean telomere-associated foci (TAF) per cardiomyocyte and the percentage of cardiomyocytes with TAF increased significantly with age, while total γH2A.X foci did not change with age.
- In purified cardiomyocytes from young (3 months) vs old (20 months) mice, RNA-seq found 416 differentially expressed genes; principal component analysis separated the groups with the first two components explaining 80.1% and 7.8% of variance.
- Aged cardiomyocytes upregulated senescence markers and hypertrophy-related genes: p16Ink4a, p21CIP, and p15Ink4b increased, and hypertrophy genes including Myh7 and Acta1 increased, but canonical SASP genes such as Il-1α, Il-1β, Il-6, Cxcl1, and Cxcl2 were not differentially expressed.
- Senescent-cell clearance improved cardiac structure: in aged INK-ATTAC mice, AP treatment reduced p16Ink4a- and eGFP-positive cells, reduced TAF in cardiomyocytes, reduced average cardiomyocyte cross-sectional area, and decreased fibrosis; navitoclax likewise significantly reduced hypertrophy and fibrosis in aged wild-type mice.
- Navitoclax increased evidence of cardiomyocyte renewal: EdU-labelled cardiomyocytes increased from 0.07% in vehicle controls to 0.23% with navitoclax.
## Methods
- The study combined in vivo ageing and intervention experiments in mice with human heart tissue from patients undergoing open-heart surgery for aortic stenosis, plus multiple cell culture systems (rat neonatal cardiomyocytes, mouse embryonic cardiomyocytes, H9C2 myoblasts, and AC10 cells).
- Telomere damage was assessed mainly by dual immuno-FISH for DDR proteins (γH2A.X, 53BP1) co-localised with telomeres, along with STED microscopy, ChIP-qPCR for γH2A.X at telomeres, SA-β-Gal staining, RNA-seq, and cytokine assays.
- Causality was tested using telomere-targeted damage (TRF1-FokI), oxidative stress/mitochondrial dysfunction models, and senescent-cell clearance via INK-ATTAC/AP20187 and the senolytic navitoclax (ABT263).
## Limitations
- The paper states that interphase telomere FISH does not identify telomeres on specific chromosomes or detect telomere-free ends; it also notes that with 3-μm tissue sections, the entirety of cardiomyocyte nuclei may not be captured.
- The authors note that although STED improved resolution, clusters of telomeres may still not be fully resolved.
- Evident from the text: several mechanistic links are correlative rather than definitively causal in vivo, and the authors explicitly say it remains possible that mitochondrial dysfunction is a consequence, rather than the cause, of telomere dysfunction.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
12 Valid · 0 Not valid · 8 Not checked · 110 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Work by us and others previously demonstrated demonstrated that stress exposure leads to activation of a persistent DDR at telomeric regions”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Results > Telomere damage is persistent in cardiomyocytes
What the sources say
- Supportedcites Fumagalli et al, 2012 matched to “Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation” (2012) source
The Results section on DDR markers during physiological ageing states that exposure to exogenous or endogenous DNA damage can produce breaks at telomeres that remain unrepaired, resulting in persistent DDR foci. This supports the claim when stress exposure refers to DNA-damaging stress. (LLM, conf=0.93)
- Supportedcites Hewitt et al, 2012 matched to “Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence” (2012) source
The paper reports that DNA damage foci induced by exogenous stress are preferentially located at telomeres and that persistent foci are associated with telomeres (Abstract). The Results section, “TAF are persistent in stress-induced senescence,” also reports enrichment of the DDR marker γH2A.X at telomere repeats 10 days after irradiation. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“pro‐inflammatory genes associated with the SASP (Coppé et al, 2008), such as Il‐1α, Il‐1β, Il‐6, Cxcl1 and Cxcl2, were not differentially expressed between CMs from young and aged animals”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Results > Aged cardiomyocytes activate senescence pathways but not a typical SASP Within the heart, CMs comprise approximately only 30% of the total cells (Nag & Zak, 1979). To overcome this heterogeneity and obtain an accurate representation of the CM transcriptome during ageing, we devised a new method for isolation and enrichment of CMs. In short, we conducted a retrograde Langendorff perfusion for dissociation of cardiomyocytes, followed by removal of CD31+/CD45+/ScaI+ interstitial cells via magnetic bead sorting (Fig 4A). This method allowed us to obtain a highly enriched cardiomyocyte population (Fig EV3A). RT–PCR quantification of mRNAs encoding the cyclin‐dependent kinase inhibitors p16Ink4a, p21CIP and p15Ink4b in 3‐ and 20‐month‐old animals demonstrated an age‐dependent increase in expression of all three genes (Fig 4B). Immunohistochemistry on tissue sections from ageing mice validated the increase of p21CIP at the protein level, specifically in CMs (Fig 4C). Furthermore, we detected increased activity of SA‐β‐Gal in old mice (Fig 4D). While SA‐β‐Gal positivity was rare, we could detect it in CMs but no other cell types from old mice. By centromere‐FISH in CMs, we also observed an age‐dependent increase of senescence‐associated distension of satellites (SADS), a marker of senescence (Swanson et al, 2013; Fig 4E). Global transcription analysis of purified CM populations by RNA‐sequencing revealed 416 differentially expressed genes between young (3 months) and old (20 months; Fig EV3B) mice. Principal component analysis revealed that both cohorts separate well with the first and second components, accounting for 80.1 and 7.8% of the cumulative variance across the data set (Fig EV3C). Consistent with rare CM proliferation in vivo, we did not observe any significant changes in the expression of proliferation genes (Fig EV3D). However, genes involved in the regulation of myofilaments, contraction and CM hypertrophy were enriched in old mice (Myh7, Capn3, Ankrd1, Myom3, Myot, Mybpc2). Confirmatory qRT–PCR showed age‐dependent increase in hypertrophy genes Myh7 and Acta1, but not Anf (Fig EV3E and F). Interestingly, pro‐inflammatory genes associated with the SASP (Coppé et al, 2008), such as Il‐1α, Il‐1β, Il‐6, Cxcl1 and Cxcl2, were not differentially expressed between CMs from young and aged animals (Fig 4F). To determine whether SASP factors were secreted by CMs, we collected conditioned medium from isolated CMs from young and old mice. In accordance with the RNA‐seq results, we did not find any significant differences in the levels of secreted proteins using a cytokine array (Fig 4F). Our data are in contrast with a previous report that shows increased expression of SASP components in murine heart with age using whole heart homogenates (Ock et al, 2016). We therefore compared the expression of previously reported SASP components in non‐purified and purified CM populations. Consistently, we found that following a simple Langendorff digestion that collects a heterogeneous population of CMs and stromal cells, we found significant differences in expression of SASP components such as Il‐6 and Cxcl1 between young and old mice (Appendix Fig S5A). However, the population of purified CMs demonstrated no such differences, suggesting that cell types other than CMs could explain previous observations (Appendix Fig S5A). Interestingly, RNA sequencing led to the identification of three secreted proteins, not commonly categorised as SASP components, which were confirmed to be significantly increased at the mRNA level in aged purified CMs: Edn3, Tgfb2 and Gdf15 (Fig 5A). Of these, only Edn3 was increased exclusively in aged CMs, but neither in cardiac stromal cells nor in other organs, suggesting that increased Edn3 levels in plasma is a good indicator of CM ageing (Appendix Fig S5B–D). The SASP has been shown to impact on proliferation of neighbouring cells, ultimately inducing senescence (Acosta et al, 2013). Consistently, we found that conditioned medium isolated from old adult CMs reduced proliferation of neonatal fibroblasts (measured by EdU incorporation) and increased the expression of α‐smooth muscle actin (α‐SMA), an indicator of myofibroblast activation (Fig 5B–E). We then examined in more detail the role of the newly identified CM senescence‐associated proteins in terms of their ability to induce bystander effects, particularly their role in fibrosis, proliferation and hypertrophy. We found that Edn3, Tgfb2 and Gdf15 induced expression of α‐SMA in fibroblasts; however, only Tgfb2 reduced cellular proliferation as measured by EdU incorporation (Fig 5F–H). Furthermore, treatment of neonatal rat CMs with Edn3 or Tgfb2, but not Gdf15, resulted in a significant increase in the cell surface area, supporting their involvement in the induction of hypertrophy (Fig 5I). Consistent with previous reports indicating that the SASP can induce senescence in neighbouring cells (Acosta et al, 2013), we found that conditioned medium from old adult CMs was able to induce an increase in SA‐β‐Gal and a reduction in EdU incorporation in fibroblasts. No significant increase in DNA damage foci was observed in fibroblasts (Appendix Fig S5E–H). We conclude that aged CMs in vivo activate a number of senescence effector pathways, including hypertrophy and a non‐typical SASP, which may mediate both autocrine and paracrine effects.
What the sources say
- Supportedcites Coppé et al, 2008 matched to “Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor” (2008) source
The citation supports the description of these as pro-inflammatory SASP-associated genes, not the citing authors’ finding about young and aged cardiomyocytes. The paper describes inflammatory cytokines and chemokines as SASP components, including IL-6, and identifies IL-1α and IL-1β as SASP factors; the cardiomyocyte comparison is not attributed to it. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“By centromere‐FISH in CMs, we also observed an age‐dependent increase of senescence‐associated distension of satellites (SADS)”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Results > Aged cardiomyocytes activate senescence pathways but not a typical SASP Within the heart, CMs comprise approximately only 30% of the total cells (Nag & Zak, 1979). To overcome this heterogeneity and obtain an accurate representation of the CM transcriptome during ageing, we devised a new method for isolation and enrichment of CMs. In short, we conducted a retrograde Langendorff perfusion for dissociation of cardiomyocytes, followed by removal of CD31+/CD45+/ScaI+ interstitial cells via magnetic bead sorting (Fig 4A). This method allowed us to obtain a highly enriched cardiomyocyte population (Fig EV3A). RT–PCR quantification of mRNAs encoding the cyclin‐dependent kinase inhibitors p16Ink4a, p21CIP and p15Ink4b in 3‐ and 20‐month‐old animals demonstrated an age‐dependent increase in expression of all three genes (Fig 4B). Immunohistochemistry on tissue sections from ageing mice validated the increase of p21CIP at the protein level, specifically in CMs (Fig 4C). Furthermore, we detected increased activity of SA‐β‐Gal in old mice (Fig 4D). While SA‐β‐Gal positivity was rare, we could detect it in CMs but no other cell types from old mice. By centromere‐FISH in CMs, we also observed an age‐dependent increase of senescence‐associated distension of satellites (SADS), a marker of senescence (Swanson et al, 2013; Fig 4E). Global transcription analysis of purified CM populations by RNA‐sequencing revealed 416 differentially expressed genes between young (3 months) and old (20 months; Fig EV3B) mice. Principal component analysis revealed that both cohorts separate well with the first and second components, accounting for 80.1 and 7.8% of the cumulative variance across the data set (Fig EV3C). Consistent with rare CM proliferation in vivo, we did not observe any significant changes in the expression of proliferation genes (Fig EV3D). However, genes involved in the regulation of myofilaments, contraction and CM hypertrophy were enriched in old mice (Myh7, Capn3, Ankrd1, Myom3, Myot, Mybpc2). Confirmatory qRT–PCR showed age‐dependent increase in hypertrophy genes Myh7 and Acta1, but not Anf (Fig EV3E and F). Interestingly, pro‐inflammatory genes associated with the SASP (Coppé et al, 2008), such as Il‐1α, Il‐1β, Il‐6, Cxcl1 and Cxcl2, were not differentially expressed between CMs from young and aged animals (Fig 4F). To determine whether SASP factors were secreted by CMs, we collected conditioned medium from isolated CMs from young and old mice. In accordance with the RNA‐seq results, we did not find any significant differences in the levels of secreted proteins using a cytokine array (Fig 4F). Our data are in contrast with a previous report that shows increased expression of SASP components in murine heart with age using whole heart homogenates (Ock et al, 2016). We therefore compared the expression of previously reported SASP components in non‐purified and purified CM populations. Consistently, we found that following a simple Langendorff digestion that collects a heterogeneous population of CMs and stromal cells, we found significant differences in expression of SASP components such as Il‐6 and Cxcl1 between young and old mice (Appendix Fig S5A). However, the population of purified CMs demonstrated no such differences, suggesting that cell types other than CMs could explain previous observations (Appendix Fig S5A). Interestingly, RNA sequencing led to the identification of three secreted proteins, not commonly categorised as SASP components, which were confirmed to be significantly increased at the mRNA level in aged purified CMs: Edn3, Tgfb2 and Gdf15 (Fig 5A). Of these, only Edn3 was increased exclusively in aged CMs, but neither in cardiac stromal cells nor in other organs, suggesting that increased Edn3 levels in plasma is a good indicator of CM ageing (Appendix Fig S5B–D). The SASP has been shown to impact on proliferation of neighbouring cells, ultimately inducing senescence (Acosta et al, 2013). Consistently, we found that conditioned medium isolated from old adult CMs reduced proliferation of neonatal fibroblasts (measured by EdU incorporation) and increased the expression of α‐smooth muscle actin (α‐SMA), an indicator of myofibroblast activation (Fig 5B–E). We then examined in more detail the role of the newly identified CM senescence‐associated proteins in terms of their ability to induce bystander effects, particularly their role in fibrosis, proliferation and hypertrophy. We found that Edn3, Tgfb2 and Gdf15 induced expression of α‐SMA in fibroblasts; however, only Tgfb2 reduced cellular proliferation as measured by EdU incorporation (Fig 5F–H). Furthermore, treatment of neonatal rat CMs with Edn3 or Tgfb2, but not Gdf15, resulted in a significant increase in the cell surface area, supporting their involvement in the induction of hypertrophy (Fig 5I). Consistent with previous reports indicating that the SASP can induce senescence in neighbouring cells (Acosta et al, 2013), we found that conditioned medium from old adult CMs was able to induce an increase in SA‐β‐Gal and a reduction in EdU incorporation in fibroblasts. No significant increase in DNA damage foci was observed in fibroblasts (Appendix Fig S5E–H). We conclude that aged CMs in vivo activate a number of senescence effector pathways, including hypertrophy and a non‐typical SASP, which may mediate both autocrine and paracrine effects.
What the sources say
- Supportedcites Swanson et al, 2013 matched to “Higher-order unfolding of satellite heterochromatin is a consistent and early event in cell senescence” (2013) source
The Results section (‘Marked distension of satellite DNA in a subset of primary human fibroblasts’; page unavailable) identifies distended centromeric satellite signals using DNA hybridization. The section on senescent murine cells likewise reports distended centromeric signals and calls this change SADS. The age-dependent cardiomyocyte finding is explicitly the citing authors’ own observation (‘we also observed’), not a finding attributed to this source. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In mouse models of accelerated telomere shortening, critically short telomeres have been shown to repress PGC1‐α‐ and β‐mediated mitochondrial biogenesis (Sahin et al, 2011; Chang et al, 2016).”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Discussion
What the sources say
- Supportedcites Sahin et al, 2011 matched to “Telomere dysfunction induces metabolic and mitochondrial compromise” (2011) source
The section “Telomere dysfunction represses PGC network and mitochondrial biogenesis” describes successive generations of telomerase-deficient mice with decreasing telomere reserves and reports reduced PGC-1α and PGC-1β expression in mice with severe telomere dysfunction. The Discussion states that these analyses established a link between telomere dysfunction and repression of PGC-dependent mitochondrial biogenesis. Page numbers are not provided in our copy. (LLM, conf=0.94)
- Supportedcites Chang et al, 2016 matched to “Telomere shortening and metabolic compromise underlie dystrophic cardiomyopathy” (2016) source
The Results (Fig. 3 legend, p. —) state 'Critically short telomeres lead to activation of p53, leading to decreased mitochondrial biogenesis' with reduced Pgc1α and Pgc1β transcripts, and the Results text concludes that 'critically shortened telomeres in dystrophin-deficient cardiomyocytes in conjunction with a DNA damage response block mitochondrial biogenesis.' The Discussion additionally describes the TERT G4 null mouse model of ubiquitous telomere shortening developing mitochondrial dysfunction 'because of p53-dependent inhibition of PGC1α/β,' and the Significance section summarizes reduced mitochondrial biogenesis via p53 activation in the humanized-telomere mdx4cv/mTR model. Thus the mouse-model attribution of short-telomere repression of PGC1α/β-mediated mitochondrial biogenesis is stated in our copy. (LLM, conf=0.90)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Our study, in accordance with others (Baker et al, 2016; Roos et al, 2016; Demaria et al, 2017), shows that the loss of senescent cardiomyocytes does not adversely alter cardiac function in aged mice.”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Discussion
What the sources say
- Partly supportedcites Baker et al, 2016 matched to “Naturally occurring p16Ink4a-positive cells shorten healthy lifespan” (2016) sourceExperimental — accuracy not yet measured
The section “p16Ink4a-positive cells contribute to cardiac aging” (page not provided) reports no significant difference in resting echocardiographic measures between treated and untreated 18-month-old mice, and preserved cardiac stress tolerance after treatment. But the paper describes clearance of p16Ink4a-positive cells, not specifically the loss of senescent cardiomyocytes; the identified senescence-marker-positive cardiac cells include pericardial epithelial cells and fibroblasts and aortic-root smooth muscle cells. (LLM, conf=0.88)
- Could not verifycites Roos et al, 2016 matched to “Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice” (2016) sourceExperimental — accuracy not yet measured
The age-related vascular pathology section reports clearance of senescent cells from the aortic vessel wall and improved carotid artery relaxation in aged mice. The copy does not report loss of senescent cardiomyocytes or assess whether their loss adversely affects cardiac function (searched: cardiomyocytes, cardiac function, heart function, echocardiography). (LLM, conf=0.74)
- Partly supportedcites Demaria et al, 2017 matched to “Cellular senescence promotes adverse effects of chemotherapy and cancer relapse” (2017) sourceExperimental — accuracy not yet measured
In Results (“Inflammation, bone marrow recovery and heart function”; page unavailable), eliminating senescent cells after doxorubicin treatment almost completely prevented declines in cardiac function. But the paper says those cardiac senescent cells were primarily endothelial cells and fibroblast-like cells, not cardiomyocytes. It therefore does not establish that loss of senescent cardiomyocytes is harmless in aged mice. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
60 more claims
Create a free account to see all 130 claims and to verify the 4 references still open.
- Probably not a substantial claim. 20
- It may state two separate claims as one. 46
- The quote only partly states this claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“genetic and pharmacological clearance of p16-expressing senescent cells ameliorated heart functions in aged mice140.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [140]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mice, despite having long telomeres and ubiquitous telomerase expression, show an age-dependent increase in dysfunctional telomeres in both proliferating and non-proliferating tissues20,34–37.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, the levels of DDR markers and TAFs increase during ageing in different mammalian tissues.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The clearance of senescent cells in aged mice improves heart functions and reduces the fraction of TAF-positive cardiomyocytes without a significant effect on mean telomere length36.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Clearance of senescent cells in aged mice and in mice with atherosclerosis using genetic and pharmacological approaches improves vascular and myocardial function and attenuates age-dependent remodelling.25,27”
From The costs and benefits of senotherapeutics for human health (2022) · cites this paper as [27]
Experimental — accuracy not yet measured
18 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Materials and Methods > Animals and procedures
“Hearts from mixed‐sex CJ57/BL6 mice were placed on a Langendorff setup.”
§ Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence > Materials and Methods > Animals and procedures
“Mixed‐sex C57BL/6 mice were analysed at either 3, 15, 20, 24 or 30 months of age.”
Citations
Cites
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 1×
“Senescence-associated b -galactosidase activity assay SA-b -Gal activity assay was performed as described previously (Dimri et al , 1995).”
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975 · cited 1×
“Telomere shortening has been proposed as a major inducer of senescence (Bodnar et al , 1998).”
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“Using this model, it has previously been shown that clearance of p16-expressing cells improves multiple parameters of physical health and function within ageing mice (Baker et al , 2011, 2016; Farr et al , 2017; Ogrodnik et al , 2017).”
Self-citationHucka, M., Finney, A., Sauro, H. M., Bolouri, H., Doyle, J. C., Kitano, H., Arkin, A. P., Bornstein, B. J., Bray, D., Cornish-Bowden, A., et al. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg015 · Cited by 3,060 · cited 1×
“The models were encoded in the Systems Biology Markup Language (SBML) modelling standard (Hucka et al , 2003) with the Python SBML shorthand tool (Wilkinson, 2011).”
Shelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917 · cited 1×
“…associated with a protein complex known as shelterin (de Lange, 2005), which facilitates the formation of a lariat-like structure to shield the exposed end of DNA (Griffith et al , 1999), thus protecting the ends of chromosomes from being recognised as DNA damage (d’Adda di Fagagna et al , 2003).”
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876 · cited 3×
“Using this model, it has previously been shown that clearance of p16-expressing cells improves multiple parameters of physical health and function within ageing mice (Baker et al , 2011, 2016; Farr et al , 2017; Ogrodnik et al , 2017).”
Self-citationCellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734 · cited 1×
“Furthermore, we found a significant increase in TAF in CMs from Polg mut/mut mice, a model of accelerated ageing due to mitochondrial dysfunction (Trifunovic et al , 2004; Fig 6G).”
Cited by
Items 301–400 of 523
Chang, F., Wu, J., Hu, S., Yi, X., Wei, Z., Tang, H., Jin, W., Zhang, Z., An, P., Luo, J., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157482 · Cited by 14
Premature senescence and cardiovascular disease following cancer treatments: mechanistic insights
Jain, A., Casanova, D., Padilla, A. V., Paniagua-Bojorges, A., Kotla, S., Ko, K. A., Samanthapudi, V. S. K., Chau, K. M., Nguyen, M. T., Wen, J. J., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1212174 · Cited by 13
“This telomere damage activates senescence-inducing pathways (p21 Cip1/Waf1 and p16I NK4a ) leading to a non-canonical SASP, contributing to age-related cardiac fi brosis and myocardial hypertrophy (77).”
BackgroundNinni, S., Algalarrondo, V., Brette, F., Lemesle, G., & Fauconnier, J. (2024) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2024.02.001 · Cited by 13
The impact of aging on cardiac repair and regeneration
Anwar, I., Wang, X., Pratt, R. E., Dzau, V. J., & Hodgkinson, C. P. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107682 · Cited by 12
“Through paracrine effects, SASP proteins impair the function of adjacent cells (78).”
BackgroundFuerlinger, A., Stockner, A., Sedej, S., & Abdellatif, M. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02566-8 · Cited by 12
Gao, H., Liu, T., Liu, J., Yang, L., Liu, L., Cui, Z., Du, X., Gu, Y., & Huang, P. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s512752 · Cited by 11
Telomeric 8-Oxoguanine Drives Rapid Premature Senescence In The Absence Of Telomere Shortening
Barnes, R. P., de Rosa, M., Thosar, S. A., Detwiler, A. C., Roginskaya, V., Van Houten, B., Bruchez, M. P., Stewart-Ornstein, J., & Opresko, P. L. (2021) · doi:10.1101/2021.05.05.442662
Translating cellular senescence research into clinical practice for metabolic disease
Chaib, S., Palmer, A. K., Wyles, S. P., Musi, N., Kirkland, J. L., & Tchkonia, T. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01187-9 · Cited by 18
“…damage 185 and fibrosis 184,185,187 Reduced hepatic steatosis 60 and liver fibrosis 188 Cardiovascular health Quercetin 189 , navitoclax 71,190–192 , dasatinib + quercetin 19,69,193 , navitoclax 69,194 Activation of resident cardiac progenitor cells and cardiomyocyte formation 193 Alleviated…”
Self-citationBalistreri, C. R., Madonna, R., & Ferdinandy, P. (2021) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2021.100027 · Cited by 13
Lewis, C. J., & de Grey, A. D. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2330425 · Cited by 10
“…of the most potent broad-spectrum senolytic drugs yet identified, its action protecting against renal fibrosis [53,54], reversing aspects of induced pulmonary fibrosis [55], reducing cardiac hypertrophy and fibrosis [56] and increasing survival time post myocardial-infarction in aged rodents [57].”
Yu, M., Song, M. O., Zhang, M., Chen, S., Ni, B., Li, X., Lei, W., Shen, Z., Fan, Y., Zhang, J. J., et al. (2025) · Cell Proliferation · doi:10.1111/cpr.70002 · Cited by 10
Banerjee, P., Olmsted‐Davis, E. A., Deswal, A. M., Nguyen, M. T. H., Koutroumpakis, E., Palaskas, N., Lin, S. H., Kotla, S., Reyes‐Gibby, C. C., Yeung, S. J., et al. (2022) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2022.13 · Cited by 11
Morgunova, V., Kordyukova, M., Mikhaleva, E. A., Butenko, I., Pobeguts, O. V., & Kalmykova, A. I. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258156 · Cited by 12
Rey‐Millet, M., Pousse, M., Soithong, C., Ye, J., Méndez-Bermúdez, A., & Gilson, É. (2023) · Aging Cell · doi:10.1111/acel.13804 · Cited by 11
“Among them, the accumulation of senescent cells appears as a major contributor to physiological and pathological aging (Anderson et al., 2019; Baker et al., 2011, 2016).”
BackgroundEllison, G. M. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1798403 · Cited by 11
Metabolic Regulation of Cardiovascular Aging
Gao, M., & Finkel, T. (2025) · Current Cardiology Reports · doi:10.1007/s11886-025-02279-8 · Cited by 11
“There is also interest in senolyt-ics-drugs that selectively eliminate senescent cells, which are sources of pro-inflammatory factors-to see if they can mitigate inflammaging and thereby protect the heart and vasculature [71].”
Salerno, N., Scalise, M., Marino, F., Filardo, A., Chiefalo, A., Panuccio, G., Torella, M., Angelis, A. D., Rosa, S. D., Ellison, G. M., et al. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10060225 · Cited by 10
“A senescence–inflammatory response is indeed key in cardiac and aging-cardiac related diseases [20,21].”
BackgroundInfluentialLi, Y., Shen, Q., Huang, L., Li, B., Zhang, Y., Wang, W., Zhao, B., & Gao, W. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03685-1 · Cited by 10
Role of the telomeric factor TRF2 in post-hypoxic brain damages
Gao, S., Huang, S., Xu, Y., Wang, B., Cheng, P., Lu, Y., Gilson, É., & Ye, J. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103278 · Cited by 9
“First, cardiomyocytes acquire a senescent-like phenotype during aging characterized by persistent DNA damage at telomeres that is driven by mitochondrial dysfunction in a telomere length-independent manner [7].”
DoxoDB: A Database for the Expression Analysis of Doxorubicin-Induced lncRNA Genes
Distefano, R., Ilieva, M. S., Madsen, J. H., Rennie, S., & Uchida, S. (2023) · Non-Coding RNA · doi:10.3390/ncrna9040039 · Cited by 10
“Consistently, the removal of senescent cells has been correlated with a reduction in the pathophysiology of cardiovascular disease and with the prevention of myocardial dysfunction in relation to chemotherapy-induced cardiotoxicity [15,50–54].”
BackgroundSchöfer, S., Laffer, S., Kirchberger, S., Kothmayer, M., Löhnert, R., Ebner, E. E., Weipoltshammer, K., Distel, M., Pusch, O., & Schöfer, C. (2024) · European Journal of Histochemistry · doi:10.4081/ejh.2024.3977 · Cited by 12
Length doesn't matter—telomere damage triggers cellular senescence in the ageing heart
Brand, T. (2019) · The EMBO Journal · doi:10.15252/embj.2019101571 · Cited by 9
“A study in The EMBO Journal (Anderson et al , 2019) provides novel insight into the process of cellular senescence in rarely dividing cells.”
InfluentialBridger, J. M., & Foster, H. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-62532-0_5 · Cited by 11
“Indeed, in post-mitotic cardiomyocytes there is an increase in DNA damage foci associated with telomeres during ageing (Anderson et al. 2019).”
BackgroundMuscle-specific programmed cell death 5 deletion attenuates cardiac aging
Naz, A., Zhang, S., An, L. K., Song, Z., Zi, Z., Wu, J., Lai, S., Mazhar, H., Xu, M., Chen, Y., et al. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.10.142 · Cited by 10
Potential Therapies to Protect the Aging Heart Against Ischemia/Reperfusion Injury
Díaz‐Vesga, M. C., Zúñiga-Cuevas, Ú., Ramírez-Reyes, A., Herrera-Zelada, N., Palomo, I., Bravo, R., & Riquelme, J. A. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.770421 · Cited by 10
“In this context, senescence markers are augmented in aged cardiomyocytes (23), which has been linked to higher risk of cardiovascular diseases (24).”
BackgroundOGG1 and MUTYH repair activities promote telomeric 8-oxoguanine induced cellular senescencePreprint
Rosa, M. D., Barnes, R. P., Nyalapatla, P. R., Wipf, P., & Opresko, P. L. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.10.536247 · Cited by 9
Recent advances in biomarkers for senescence: Bridging basic research to clinic
Fukumoto, T., Shimosawa, T., Yakabe, M., Yoshida, S. Y., & Yoshida, Y. (2025) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.15054 · Cited by 9
Is Senolytic Therapy in Cardiovascular Diseases Ready for Translation to Clinics?
Yang, Z., Potenza, D. M., & Ming, X. (2025) · Biomolecules · doi:10.3390/biom15040545 · Cited by 13
“Senescent cardiomyocytes show upregulation of p21 cip1 , p16 ink4 , and SASP and exhibit pro-fibrotic and pro-hypertrophic features in aging mouse models [24,25].”
InfluentialMitochondrial metabolism and epigenetic crosstalk drive SASP
Martini, H., Birch, J., Marques, F. M., Victorelli, S. G., Lagnado, A. B., Pirius, N., Franco, A. C., Lee, G., Han, Y., Rowsey, J. L., et al. (2026) · Nature · doi:10.1038/s41586-026-10791-2 · Cited by 22
“However, CTPI2 specifically reduced cardiomyocyte-associated secretory factors ( Gdf15 and Edn3 ) 23 in the whole heart, consistent with reduced cardiomyocyte hypertrophy.”
Self-citationMicrophthalmia-Associated Transcription Factor in Senescence and Age-Related Diseases
Zhang, J., Mou, Y., Gong, H., Chen, H., & Xiao, H. (2021) · Gerontology · doi:10.1159/000515525 · Cited by 9
Trajano, L. A. D. S. N., Sergio, L. P. D. S., de Oliveira, D. S. L., Trajano, E. T. L., Silva, M. A. D. S., de Paoli, F., Mencalha, A. L., & da Fonseca, A. D. S. (2021) · Photochemical & Photobiological Sciences · doi:10.1007/s43630-021-00051-9 · Cited by 9
Matsunaga, T., Roesel, M. J., Schroeter, A., Xiao, Y., Zhou, H., & Tullius, S. G. (2022) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000001019 · Cited by 9
The Role of Blood-Derived Factors in Protection and Regeneration of Aged Tissues
Höving, A. L., Schmidt, K. E., Kaltschmidt, B., Kaltschmidt, C., & Knabbe, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179626 · Cited by 8
“For instance, Anderson and colleagues described an age-dependent senescence mechanism in mouse cardiomyocytes that consists of telomere damage but not telomere shortening [9].”
BackgroundNetwork of extracellular vesicles surrounding senescent cells
Okawa, H., Tanaka, Y., & Takahashi, A. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.109953 · Cited by 8
Mechanistic role of RND3-regulated IL33/ST2 signaling on cardiomyocyte senescence
Wu, L., Zhu, X., Luo, C., Zhao, Y., Pan, S.-S., Shi, K., Chen, Y., Qiu, J., Shen, Z., Guo, J., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122701 · Cited by 7
Liu, Z., Sun, C. J., Zhang, Z., Jiang, Y., & Zhao, C. (2025) · Biogerontology · doi:10.1007/s10522-025-10228-9 · Cited by 14
“As observed in cardiomyocytes (Anderson et al. 2019) and other post-mitotic tissues in mice (Fielder et al. 2020; X. Zhang et al. 2022), telomere-associated DNA damage occurs in a manner independent of telomere length.”
S913 phosphorylation of Ulk1 protects the heart from aging through inhibition of cardiac senescence
Zhai, P., Sung, E., Takayama, K., Ikeda, S., Matsushita, M., Nakada, Y., Tian, Y., & Sadoshima, J. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf129 · Cited by 8
Marrow Adipocyte Senescence in the Pathogenesis of Bone Loss
Froemming, M. N., Khosla, S., & Farr, J. N. (2024) · Current Osteoporosis Reports · doi:10.1007/s11914-024-00875-1 · Cited by 7
Wang, L., Deng, Z., Li, Y., Wu, Y., Yao, R.-Q., Cao, Y., Wang, M., Zhou, F., Zhu, H., & Kang, H. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05486-z · Cited by 10
“Telomere damage can activate the pro-aging pathways p21 and p16 in cardiomyocytes, leading to non-classical profibrotic and prohypertrophic aging-related secretory phenotypes [34].”
BackgroundYousef, A., Fang, L., Heidari, M., Kranrod, J. W., & Seubert, J. M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1486717 · Cited by 10
Petrocelli, J. J., de Hart, N. M. M. P., Lang, M. J., Yee, E. M., Ferrara, P. J., Fix, D. K., Chaix, A., Funai, K., & Drummond, M. J. (2023) · Aging · doi:10.18632/aging.204600 · Cited by 8
3D Super-Resolution Nuclear Q-FISH Imaging Reveals Cell-Cycle-Related Telomere Changes
Pochechueva, T., Schwenzer, N., Kohl, T., Brandenburg, S., Kaltenecker, G., Wollnik, B., & Lehnart, S. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063183 · Cited by 7
“Most Q-FISH studies, including the only available STED study [22], have intrinsic methodological limitations that can result in limited accuracy of telomere detection and hence quantification.”
MethodCardioprotective response and senescence in aged sEH null female mice exposed to LPS
Yousef, A., Sosnowski, D. K., Fang, L., Legaspi, R. J., Korodimas, J., Lee, A., Magor, K. E., & Seubert, J. M. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00706.2023 · Cited by 8
A Narrative Review of Circular RNAs in Brain Development and Diseases of Preterm Infants
Gu, Q., Liu, H., Ma, J., Yuan, J., Li, X., & Qiao, L. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.706012 · Cited by 9
Gu, X., Du, Y., Zhang, J., Li, J., Chen, H., Lin, Y., Wang, Y., Zhang, C., Lin, S., Hao, N., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70344 · Cited by 8
Mechanical Stress Triggers Premature Senescence in Cardiac Fibroblasts
Schneider, S. E., Scott, A. K., Gallagher, K. M., Miller, E. Y., Ghosh, S., & Neu, C. P. (2025) · Advanced Science · doi:10.1002/advs.202513314 · Cited by 9
Cellular senescence as a therapeutic target for aging intervention
Bi, Y., & Ji, G. (2026) · Biomedical Journal · doi:10.1016/j.bj.2026.100948 · Cited by 11
“In post-mitotic lineages, where proliferative arrest is non-informative, senescence is inferred from persistent stress signalling with chromatin and transcriptional rewiring, organellar dysfunction, and sustained SASP-like outputs that propagate non-cell-autonomous effects [16,17].”
Passanisi, V. J., & Spencer, S. L. (2026) · iScience · doi:10.1016/j.isci.2026.114801 · Cited by 7
“Notably, published evidence has established that telomeres commonly produce a DDR at a wide variety of lengths, 17,29,31,46,53–58 and dysfunctional telomeres are usually detectable by Q-FISH.”
SMUG1 regulates fat homeostasis leading to a fatty liver phenotype in mice
Carracedo, S., Lirussi, L., Alsøe, L., Segers, F. M., Wang, C., Bartošová, Z., Bohov, P., Tekin, N. B., Kong, X. Y., Esbensen, Q. Y., et al. (2022) · DNA repair · doi:10.1016/j.dnarep.2022.103410 · Cited by 8
Assessing Frailty in Gastrointestinal Cancer: Two Diseases in One?
Patel, I. A., & Winer, A. (2024) · Current Oncology Reports · doi:10.1007/s11912-023-01483-5 · Cited by 9
The senescent heart and atrial fibrillation
Pandey, A. C., Bidaoui, G., Younes, H., Tsakiris, E., & Marrouche, N. F. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.06.005 · Cited by 7
Genetic basis of cardiovascular aging is at the core of human longevity
Marian, A. J. (2022) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2022.06 · Cited by 7
“Length-independent telomere dysfunction also leads to cardiac myocyte senescence[48].”
BackgroundRejuvenation of the Aging Heart: Molecular Determinants and Applications
Alibhai, F. J., & Li, R. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.03.004 · Cited by 8
Recent Developments in Small-Molecule Fluorescent Probes for Cellular Senescence
Park, J. L., Lee, Y., & Park, J. (2024) · Chemosensors · doi:10.3390/chemosensors12070141 · Cited by 7
“The upregulation of MAOs in senescent cells, as well as their related effects in producing mitochondrial ROS, has been widely reported [62].”
BackgroundInfluentialSenescence as a therapeutic target
Meyer, K. R., Lopez-Dominguez, J. A., Maus, M., Kovatcheva, M., & Serrano, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00014-6 · Cited by 6
The potential of flavonoids to mitigate cellular senescence in cardiovascular disease
Zheng, H., Li, T., Hu, Z., Zheng, Q., & Wang, J. (2024) · Biogerontology · doi:10.1007/s10522-024-10141-7 · Cited by 6
“Anderson et al. discovered that increased mitochondrial ROS generation may underlie cardiac senescence (Anderson et al. 2019).”
InfluentialTang, H., Zhang, X., Hu, S., Song, Y., Jin, W., Zou, J., Zhang, Y., Guo, J., An, P., Luo, J., et al. (2025) · Targets · doi:10.3390/targets3030023 · Cited by 13
“During aging, cardiomyocytes undergo a variety of physiological alterations that directly impair their functional and structural integrity [48].”
The impact of cellular senescence on aging skeletal muscle
Kamal, M. J., Bevington, R. T., Johnson, A., & Parise, G. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1719279 · Cited by 8
“Several terminally differentiated cells have been found to accumulate multiple senescence markers with aging, including neurons, cardiomyocytes, cochlear cells and osteocytes (Jurk et al., 2012; Anderson et al., 2019; Farr et al., 2016; Benkafadar et al., 2019).”
Endothelial ZBTB16: a molecular shield against cardiac aging
Stilz, K. A., Leonard, V. E., Morales, D. R., Glaser, S.-F., Larcher, V., Jurado, M. R., Malacarne, P. F., Manickam, N., Tombor, L., Abplanalp, W. T., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf1063 · Cited by 5
Cellular senescence in age-related cardiovascular disease: past and future
Wu, X., Zhou, Q. S., Huang, Y., Jiang, W., Zhou, J., Qian, K., Pan, Y. P., Wu, Z., Zhang, J., Aimaiti, M., et al. (2026) · Frontiers in Aging · doi:10.3389/fragi.2025.1721744 · Cited by 10
“…et al. recently identified a senescent phenotype in aged mouse cardiomyocytes, featuring the expression of cyclin-dependent kinase inhibitors (CDKIs) p16Ink4a and p21Cip1 and the induction of senescence-associated β - galactosidase (SA-β -gal) activity (Anderson et al., 2019; Ye et al., 2021).”
InfluentialSelf-limiting bidirectional positive feedback between P53 and P21 is involved in cardiac hypertrophy
Hong, J., Ding, Y., Li, J., Pan, X., Liu, Y., & Zhang, H. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175239 · Cited by 5
Time’s imprint on the left atrium: aging and atrial myopathy
Gyberg, D. J., Patel, R. B., & Zhang, M. J. (2025) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2024.23 · Cited by 7
“Although senescent cardiomyocytes do not exhibit a typical senescence-associated secretory phenotype, they release factors such as endothelin-3, transforming growth factor beta-2, and growth differentiation factor 15 that promote myofibroblast activation and cardiomyocyte hypertrophy [86] .”
Senolytics rejuvenate the reparative activity of human cardiomyocytes and endothelial cells
Sunderland, P., Al-Shammari, L. A. C., Ambrose, E., Torella, D., & Ellison, G. M. (2023) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2023.07 · Cited by 8
Estep, K. N., Tobias, J. W., Fernandez, R. J., Beveridge, B. M., & Johnson, F. B. (2023) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjad058 · Cited by 5
The potential for senotherapy as a novel approach to extend life quality in veterinary medicine
Williams, Z. J., Chow, L., Dow, S., & Pezzanite, L. M. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1369153 · Cited by 6
“Aged mice treated with navitoclax had a significantly reduced number of telomere associated foci, fibrosis and reduced SC, but there was no difference in cardiac ejection fraction or left ventricle mass compared with controls (123).”
SATB1, senescence and senescence‐related diseases
Qi, W., Bai, J., Wang, R., Zeng, X., & Zhang, L. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31327 · Cited by 6
“…LCH disease (Bigenwald et al., 2021). prevents age ‐ related bone loss (Farr et al., 2017), alleviates detrimental features of cardiac aging (Anderson et al., 2019), improves glucose metabolism and β ‐ cell function (Aguayo ‐ Mazzucato et al., 2019) and preserves cognitive function (Bussian…”
Non-human primate studies for cardiomyocyte transplantation—ready for translation?
von Bibra, C., & Hinkel, R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1408679 · Cited by 9
H 2 S Donor SPRC Ameliorates Cardiac Aging by Suppression of JMJD3, a Histone Demethylase
Li, S., Li, Q., Xiang, H., Wang, C., Zhu, Q., Ruan, D., Zhu, Y. Z., & Mao, Y. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2024.0605 · Cited by 7
Cicalese, S. M., Okuno, K., & Eguchi, S. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000934 · Cited by 6
Sénothérapies: Avancées et nouvelles perspectives cliniques
Véret, D., & Brondello, J. (2020) · médecine/sciences · doi:10.1051/medsci/2020220 · Cited by 6
Impact of Aging and Cellular Senescence in the Pathophysiology of Preeclampsia
Suvakov, S. R., Kattah, A. G., Gojković, T., Enninga, E. A. L., Pruett, J. E., Jayachandran, M., Sousa, C., Santos, J., Hassan, C. A., Suarez, M. L. G., et al. (2023) · Comprehensive physiology · doi:10.1002/cphy.c230003 · Cited by 6
“Much of this stems from mechanisms of mitochondrial dysregulation which lead to the release of ROS, resulting in oxidative damage and telomere shortening associated with senescence (14, 335).”
Zhang, Y., Dai, L., Wang, M., Zhong, X., Liu, X., Zhang, K., Luo, L., Wang, L., Dong, W., Váczy, A., et al. (2025) · Diabetes · doi:10.2337/db25-0077 · Cited by 5
Senescence: An Overlooked VSMC Phenotype and Therapeutic Opportunity?
Herman, A. B., Grešová, K., Maragkakis, M., & Autieri, M. V. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.323131 · Cited by 9
Zhang, Y., Luo, R., Sun, X., et al. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-05303-5 · Cited by 4
Decoding senescent drivers in Alzheimer's disease: From bench to bedside
Zhou, R., Lin, X., Liao, Z., Lin, J., Zheng, R., Ni, H., Liu, W., Feng, Z., He, Q., Lin, X., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102978 · Cited by 4
DNA damage and repair in cardiomyopathy: mechanisms and therapeutic opportunities
Zhou, X., Yu, Z., Chen, Z., Evans, S. Μ., & Chen, J. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00774.2025 · Cited by 6
Neuregulin-1 reduces Doxorubicin-induced cardiotoxicity by upregulating YAP to inhibit senescence
Shi, H., Zou, Y., Li, Y., Li, Y., & Liu, B. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113278 · Cited by 6
Echocardiographic evaluation of cardiac reserve to detect subtle cardiac dysfunction in mice
Wang, X., Wei, Z., Wang, P., Zhou, J., Feng, M., Li, M., Liu, M., Wang, J., Zhang, X., Gao, F., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122079 · Cited by 6
Kamal, M. J., Shanmuganathan, M., Kroezen, Z., Joanisse, S., Britz‐McKibbin, P., & Parise, G. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00880.2024 · Cited by 7
Zinc Signaling in Aging Heart Function
Turan, B., Billur, D., & Olğar, Y. (2019) · Springer eBooks · doi:10.1007/978-981-15-0557-7_8 · Cited by 4
Liu, D., Aziz, N. A., Imtiaz, M. A., Pehlivan, G., & Breteler, M. M. B. (2023) · GeroScience · doi:10.1007/s11357-023-00914-2 · Cited by 4
“Decreases in telomere length in cardiomyocytes induced apoptosis and heart disease [79, 80].”
BackgroundThe Role of Telomeres in Senescence, Aging and Disease: Fiction and Reality
Saretzki, G. C. (2025) · OBM Geriatrics · doi:10.21926/obm.geriatr.2503324 · Cited by 4
Interconnected Pathways and Therapeutic Implications for Cardiovascular Aging and Diseases
Bai, X., Zhang, Y., Qu, J. T., & Liu, G. (2025) · JACC Asia · doi:10.1016/j.jacasi.2025.10.017 · Cited by 3
The Yin and Yang of cellular senescence in ischemia-induced myocardial injury
Gudenberg, R. W. V., Iske, J., Roeschl, T., Stawowy, P., Kirkland, J. L., Ruhparwar, A., & Tullius, S. G. (2025) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2025.12.004 · Cited by 6
Self-citationOldershaw, R. A., Richardson, G. D., Carling, P. J., Owens, W. A., Lundy, D. J., & Meeson, A. P. (2022) · Biomedicines · doi:10.3390/biomedicines10123143 · Cited by 4
Self-citationDichotomy between the transcriptomic landscape of naturally versus accelerated aged murine hearts
Majo, F. D., Hegenbarth, J.-C., Rühle, F., Bär, C., Thum, T., de Boer, M., Duncker, D. J., Schroen, B. L. M., Armand, A., Stoll, M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-65115-9 · Cited by 4
Hypoglychemic activity of Moringa oleifera extract in streptozotocin-induced diabetic rats
Adawiyah, R., Setyawati, T., Badaruddin, R., & Listawati (2024) · Acta Biochimica Indonesiana · doi:10.32889/actabioina.130 · Cited by 2
Novel Therapeutic Strategies Targeting Fibroblasts to Improve Heart Disease
Li, Y. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31504 · Cited by 4
“However, whether senescence serves a causal role in fibrogenesis or is merely a concomitant phenomenon remains uncertain (Anderson et al. 2019) (Figure 4).”
Targeting Cardiomyocyte PCNA and POLD1 Prevents Pathologic Myocardial Hypertrophy
Pal, S., Glennon, M. S., Nixon, B. R., Chetkof, E. J., Shridhar, P., Kathiresan, C. M., Glasser, M. B., Waldron, C. J., Guo, L., Clavere, N. G., et al. (2025) · Circulation Research · doi:10.1161/circresaha.124.325647 · Cited by 4
“67,69,70 However, the role of senescence in regulating cardiomyocyte hypertrophy is less clear because targeting myocardial senescence in a non-cell type–selective manner reduced aging-related cardiomyocyte hypertrophy but did not reduce cardiomyocyte hypertrophy secondary to ischemia reperfusion.”
Qiu, G., Fu, M., Zheng, X., & Huang, C. (2024) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.13151 · Cited by 4
“Moreover, dysfunctional telomeres that are eroded exhibit an age-dependent increase in both proliferating and non-proliferating tissues of mice as well as in humans (Anderson et al ., 2019; Rossiello et al ., 2022).”
The role of senescence in cancer therapy-associated cardiovascular toxicity
Alshoubaki, Y. K., Grüterich, V., Zollet, V., & Kuster, G. M. (2024) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2024.14 · Cited by 2
Castro, C., Delwarde, C., Shi, Y., & Roh, J. D. (2025) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2024.15 · Cited by 3
“The drivers of senescence in aged cardiomyocytes are multifold, including DNA damage, telomere damage, oxidative stress, NFkB signaling, and TGF β signaling [28,79,80] .”
InfluentialCellular senescence and senotherapeutics in cardiovascular diseases
Pal, A. (2025) · Advances in pharmacology · doi:10.1016/bs.apha.2025.01.019 · Cited by 2
Jaber‐Hijazi, F., Arnold, R., Swaminathan, K., Gilroy, K. L., Wenzel, A. T., Lagnado, A. B., Kirschner, K., Robertson, N., Reid, C., Fullarton, N. J., et al. (2025) · Aging Cell · doi:10.1111/acel.70070 · Cited by 4
“Regardless of their origin, TAFs are often associated with cell senescence and aging (Victorelli et al. 2019; Ogrodnik et al. 2017; Anderson et al. 2019; Herbig et al. 2006; Hewitt et al. 2012, 2016; Birch et al. 2015; Fumagalli et al. 2012), including in skin melanocytes (Victorelli et al. 2019).”
Self-citationMalic enzyme 1 reverses cardiomyocyte senescence in a nitric oxide-dependent manner
Wu, W., Lei, R., Xu, H., Lü, L., Song, C., Wu, D., Li, M., Chen, L., Yu, Y., & Fang, X. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.07.048 · Cited by 4
Hu, S., Li, Z., Zhu, D., Liu, S., Xing, M. M. Q., & Cheng, K. (2025) · Advanced Materials · doi:10.1002/adma.202418352 · Cited by 8
The Role of Lactate in Mitochondrial Metabolism of DOX‐Induced Senescent AC16 Cells
Militello, R., Luti, S., Gamberi, T., Leri, M., Santi, A., Becatti, M., Pellegrino, A., Modesti, P. A., & Modesti, A. (2025) · Cell Biochemistry and Function · doi:10.1002/cbf.70110 · Cited by 3
“Mitochondrial dysfunction and alteration of metabolism pattern are the keys feature of cardiomyocyte senescence [12, 13] that in turn contributes to cardiac aging, dysfunction, and failure [9].”
An, J., Su, H., Wang, X., Zhang, G., Xiao, C.-D., Wollenberga, B., Chen, Y.-X., Yang, H., Luo, H., Yang, L., et al. (2025) · Chinese Medicine · doi:10.1186/s13020-025-01254-3 · Cited by 2
Fang, Y., Yang, B., Zhu, D., Zhang, X., Jiang, X., Wang, H., Zhang, L., Yu, Y., Yang, Y., Yuan, M., et al. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2025.116108 · Cited by 3
Sun, J., Xie, K., Cao, Y., Kang, L., & Li, R. (2026) · Cardiovascular Toxicology · doi:10.1007/s12012-026-10105-y · Cited by 2
“An emerging concept in cardiovascular research is that cellular senescence contributes to pathological remodeling and loss of cardiac reserve [ 26 , 27 ].”
Metadata
- Authors
- Anderson, R., Lagnado, A., Maggiorani, D., Walaszczyk, A., Dookun, E., Chapman, J., Birch, J., Salmonowicz, H., Ogrodnik, M., Jurk, D., Proctor, C., Correia‐Melo, C., Victorelli, S., Fielder, E., Berlinguer‐Palmini, R., Owens, A., Greaves, L. C., Kolsky, K. L., Parini, A., Douin‐Echinard, V., LeBrasseur, N. K., Arthur, H. M., Tual‐Chalot, S., Schafer, M. J., Roos, C. M., Miller, J. D., Robertson, N., Mann, J., Adams, P. D., Tchkonia, T., Kirkland, J. L., Mialet‐Perez, J., Richardson, G. D., & Passos, J. F.
- Affiliations
- Newcastle University (GB)
- Inserm (FR)
- Mayo Clinic (US)
- Wellcome Centre for Mitochondrial Research (GB)
- Cancer Research UK Scotland Institute (GB)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Corresponding author
- Mialet‐Perez, Jeanne
- Richardson, Gavin D
- Passos, João F
- ORCID
- Lagnado, Anthony
- Maggiorani, Damien
- Walaszczyk, Anna
- Dookun, Emily
- Chapman, James
- Birch, Jodie
- Salmonowicz, Hanna
- Ogrodnik, Mikolaj
- Jurk, Diana
- Proctor, Carole
- Correia‐Melo, Clara
- Victorelli, Stella
- Fielder, Edward
- Berlinguer‐Palmini, Rolando
- Greaves, Laura C
- Parini, Angelo
- Douin‐Echinard, Victorine
- LeBrasseur, Nathan K
- Arthur, Helen M
- Tual‐Chalot, Simon
- Schafer, Marissa J
- Miller, Jordan D
- Robertson, Neil
- Mann, Jelena
- Adams, Peter D
- Kirkland, James L
- Mialet‐Perez, Jeanne
- Richardson, Gavin D
- Passos, João F
- Venue
- The EMBO Journal
- Published
- 2019-02-08
- Volume
- 38
- Issue
- 5
- Pages
- e100492
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC6396144
- OpenAlex
- W2913284769
- Semantic Scholar
- f2b575f4b8dabea90337c591a95d86658c57701d
- Cited by
- 532
- References
- 60
- Citations by year
- 2026: 59 · 2025: 80 · 2024: 83 · 2023: 68 · 2022: 77 · 2021: 70 · 2020: 67 · 2019: 28
- FWCI
- 41.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The EMBO Journal (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- Connor Group
- Noaber Foundation
- Région Occitanie, France
- Medical Research Council and Arthritis UK funded centre for integrated Musculoskeletal Ageing (MR/K0063121/1)
- RCUK | Biotechnology and Biological Sciences Research Council (BB/H022384/1, BB/K017314/1)
- British Heart Foundation (PG/15/85/31744)
- Foundation for the National Institutes of Health (AG013925)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- cardiomyocyte senescence, cellular senescence, cardiac aging, senolytics, senescence-associated secretory phenotype, p21, p16INK4a, mitochondrial dysfunction, myocardial fibrosis, cardiac hypertrophy, age-related cardiac dysfunction
- MeSH terms
- Aging, Animals, DNA Damage, Female, Fibrosis, Cardiomegaly, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Mitosis, Monoamine Oxidase, Phenotype, RNA, Cellular Senescence, Rats, Sprague-Dawley, Mice, Knockout, Telomerase, Myocytes, Cardiac, Mice, Telomere Shortening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.